ArticleOncoTargets and therapy2017

Bisdemethoxycurcumin in combination with α-PD-L1 antibody boosts immune response against bladder cancer.

Yiqun Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.